About Penta
Who we are
Our Strategy
Our Network
Working Groups
Penta Foundation
Our Staff
Diversity and Inclusion
Annual reports
Our Activities
News & Webinars
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Calls for service
PentaTr@ining
Archivio
Is pregnancy a barrier to the proposed lower dose of efavirenz?
Timing of the postpartum curve in pharmacokinetic studies in pregnancy should not be too early
A Comparison of the Pharmacokinetics of Efavirenz During Pregnancy and Postpartum
Etravirine Pharmacokinetics in HIV-Infected Pregnant Women